Follicular lymphoma grade IIIb, unspecified site
ICD-10 C82.40 is a billable code used to indicate a diagnosis of follicular lymphoma grade iiib, unspecified site.
Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade IIIb indicates a more aggressive form of the disease, where more than 50% of the tumor consists of large cells, which can lead to a more rapid progression and poorer prognosis compared to lower grades. This subtype is often diagnosed in adults and can present with various symptoms, including lymphadenopathy, splenomegaly, and B-symptoms such as fever, night sweats, and weight loss. The unspecified site indicates that the lymphoma is not localized to a specific anatomical location, which can complicate treatment planning and staging. Treatment typically involves a combination of chemotherapy, immunotherapy, and sometimes radiation therapy, depending on the stage of the disease and the patient's overall health. Regular monitoring and follow-up are crucial due to the potential for transformation into a more aggressive lymphoma.
Detailed clinical notes on diagnosis, staging, treatment plans, and follow-up care.
Initial diagnosis of follicular lymphoma, treatment planning, and management of relapsed disease.
Accurate grading and staging are crucial for treatment decisions and prognosis.
Histopathological reports detailing the grade and subtype of lymphoma.
Biopsy interpretation and grading of lymphoid tissue.
Clear communication of findings to ensure accurate coding and treatment planning.
Used for administering chemotherapy to patients with follicular lymphoma.
Document the drug administered, dosage, and patient response.
Oncology specialists must ensure accurate coding of chemotherapy regimens.
Common symptoms include painless swelling of lymph nodes, fever, night sweats, weight loss, and fatigue. Patients may also experience splenomegaly.
